Eyas Raddad

Associate VP- Portfolio Strategy and New Platforms-Diabetes Research at Eli Lilly and Company

Role
Associate Vp- Portfolio Strategy and New Platforms-diabetes Research at Eli Lilly and Company
Location
Indianapolis, IN, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

Experience

  1. Associate Vp- Portfolio Strategy and New Platforms-diabetes Research

    Eli Lilly and Company

    Mar 2022 — Present · IN, US

Education

  • Massachusetts Institute of Technology - Sloan School of Management

    Master of Business Administration (MBA), Executive MBA

    2011 — 2013

  • University of Jordan

    BPharm, Pharmacy

    1992 — 1997

  • The University of Georgia

    PhD, Pharmacokinetics

    1997 — 2001

Skills

  • Biomarkers
  • Regulatory Submissions
  • In Vivo
  • Leadership
  • Translational Medicine
  • Pk/Pd
  • Drug Discovery
  • In Vitro
  • Drug Metabolism
  • Dmpk
  • Clinical Trials
  • Ind
  • Adme
  • Biotechnology
  • Clinical Research
  • Clinical Pharmacology
  • Drug Development
  • Clinical Development
  • Bioanalysis
  • Drug Delivery
  • Pharmacokinetics
  • Pharmacodynamics
  • Life Sciences
  • Business Strategy
  • Oncology
  • Toxicology
  • CRO
  • Lead Change
  • Pharmacology
  • Pharmaceutical Industry
  • Cross-Functional Team Leadership
  • Glp

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Eyas Raddad — Associate Vp- Portfolio Strategy and New Platforms-diabetes Research at Eli Lilly and Company in Indianapolis, IN, US | Unifers